Cloudpharm participated in the EU HORIZON-funded project “ENVIROMED” Plenary Meeting in January 21-22 2025, held in Linz, Austria with the project’s consortium partners to review progress and align on key outcomes. The meeting provided a valuable forum to exchange...
In this editorial, we argue for a holistic view of evidence-based practices via the synergy of human and artificial intelligence in drug discovery. This strategy may build a collaborative conceptual framework to enable better-informed and rapid decisions, and the...
FRUITPRINT’s (HORIZON Europe) kick-off meeting was held with high participation and excitement in Toulouse on Tuesday, 28 January at The Social Hub. CLOUDPHARM participated in the meeting as one of the 12 project beneficiaries. The event brought together, physically,...
Cloudpharm supports the “Targeted Drug Discovery” workshop, which is the first interactive workshop in Greece focusing on the Drug design and development pipeline aiming to integrate all the related topics from structure-based drug design to preclinical...
From 19th to 21st March 2025, Cloudpharm hosted the 5th One Health Drugs (OHD) Training School on In-Silico Prediction Methods for Ecotoxicity and Bioaccumulation. The event featured hands-on training sessions, engaging lectures and lively discussions, giving the...
Cloudpharm was present at Vitafoods 2025 in Barcelona, exploring the latest trends in ingredients, delivery systems and supplement formats. The visit provided valuable insights into the state-of-the-art of emerging biotechnological companies, ensuring that our...
